The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial
Open accessAbstract
BACKGROUND: Lactose intolerance (LI) is a common medical problem with limited treatment options. The primary symptoms are abdominal pain, diarrhea, bloating, flatulence, and cramping. Limiting dairy foods to reduce symptoms contributes to low calcium intake and the risk for chronic disease. Adaptation of the colon bacteria to effectively metabolize lactose is a novel and potentially useful approach to improve lactose digestion and tolerance. RP-G28 is novel galacto-oligosaccharide (GOS) being investigated to improve lactose digestion and the symptoms of lactose intolerance in affected patients. METHODS: A randomized, double-blind, parallel group, placebo-controlled study was conducted at 2 sites in the United States. RP-G28 or placebo was administered to 85 patients with LI for 35 days. Post-treatment, subjects reintroduced dairy into their daily diets and were followed for 30 additional days to evaluate lactose digestion as measured by hydrogen production and symptom improvements via a patient-reported symptom assessment instrument. RESULTS: Lactose digestion and symptoms of LI trended toward improvement on RP-G28 at the end of treatment and 30 days post-treatment. A reduction in abdominal pain was also demonstrated in the study results. Fifty percent of RP-G28 subjects with abdominal pain at baseline reported no abdominal pain at the end of treatment and 30 days post treatment (p = 0.0190). RP-G28 subjects were also six times more likely to claim lactose tolerance post-treatment once dairy foods had been re-introduced into their diets (p = 0.0389). CONCLUSIONS: Efficacy trends and favorable safety/tolerability findings suggest that RP-G28 appears to be a potentially useful approach for improving lactose digestion and LI symptoms. The concurrent reduction in abdominal pain and improved overall tolerance could be a meaningful benefit to lactose intolerant individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lower levels of lactose/galactose degradation may explain increased lactose intolerance in older adults and presents a possible opportunity for microbial therapeutic intervention (Gingold-Belfer et al., 2020; Savaiano et al., 2013).”
From Gut microbiome stability and dynamics in healthy donors and patients with non-gastrointestinal cancers (2021) · cites this paper as Savaiano et al., 2013
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ross, A. C., Manson, J. E., Abrams, S. A., Aloia, J. F., Brannon, P. M., Clinton, S. K., Durazo-Arvizu, R. A., Gallagher, J. C., Gallo, R. L., Jones, G., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2704 · Cited by 4,026 · cited 1×
“Low calcium consumption increases the risk for chronic diseases, most notably osteoporosis and its sequelae [18].”
BackgroundThe functional gastrointestinal disorders and the Rome III process
Drossman, D. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.008 · Cited by 2,416
Scrimshaw, N. S., & Murray, E. B. (1988) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/48.4.1142 · Cited by 431 · cited 2×
“In the United States, it is estimated that up to 80 million Americans have the potential for lactose intolerance [1].”
BackgroundColonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance
Hertzler, Sr., & Savaiano, D. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/64.2.232 · Cited by 266 · cited 4×
“Adaptation of the gut can turn symptomatic LI patients into lactose digesters [9] despite the underlying genetically-controlled biology of low intestinal lactase activity.”
BackgroundInfluentialSelf-citationColonic conservation of malabsorbed carbohydrate
Bond, J. H., Currier, B. E., Buchwald, H., & Levitt, M. D. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90854-9 · Cited by 220
Obermayer-Pietsch, B. M., Bonelli, C. M., Walter, D. E., Kuhn, R. J., Fahrleitner-Pammer, A., Berghold, A., Goessler, W., Stepan, V., Dobnig, H., Leb, G., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301207 · Cited by 168 · cited 1×
“By avoiding dairy products, many lactose intolerant individuals in the US and other developed countries have lower bone density [17].”
BackgroundNIH consensus development conference statement: Lactose intolerance and health.
Suchy, F. J., Brannon, P. M., Carpenter, T. O., Fernández, J. R., Gilsanz, V., Gould, J. B., Hall, K., Hui, S. L., Lupton, J. R., Mennella, J. A., et al. (2010) · PubMed · Cited by 157
Lactose malabsorption and intolerance and peak bone mass
Stefano, M. D., Veneto, G., Malservisi, S., Cecchetti, L., Minguzzi, L., Strocchi, A., & Corazza, G. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.33600 · Cited by 139
Andersen, J. M., Barrangou, R., Hachem, M. A., Lahtinen, S. J., Goh, Y. J., Svensson, B., & Klaenhammer, T. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114152108 · Cited by 133 · cited 1×
“GOS preparations have been shown to stimulate microfloral changes [19].”
BackgroundSelf-citationHow Much Lactose is Low Lactose?
Hertzler, S. R., HUYNH, B.-C. L., & Savaiano, D. A. (1996) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(96)00074-0 · Cited by 117 · cited 1×
“With the calculation of total hydrogen production, literature reports indicate a lactose challenge of 6, 12, or 20 g result in mean total 8-hour hydrogen productions of 145, 292, and 488 ppm above baseline, respectively, with SDs of approximately 126 ppm [15].”
BackgroundSelf-citation
Cited by
Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management
Misselwitz, B., Butter, M., Verbeke, K., & Fox, M. R. (2019) · Gut · doi:10.1136/gutjnl-2019-318404 · Cited by 390
Lactose Intolerance, Dairy Avoidance, and Treatment Options
Szilagyi, A., & Ishayek, N. (2018) · Nutrients · doi:10.3390/nu10121994 · Cited by 249
Azcarate-Peril, M. A., Ritter, A. J., Savaiano, D., Monteagudo-Mera, A., Anderson, C., Magness, S. T., & Klaenhammer, T. R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606722113 · Cited by 231
“Savaiano et al. conducted a randomized, double-blind, parallel-group, placebocontrolled study at two sites in the United States (4).”
BackgroundMethodInfluentialSelf-citationUpdate of probiotics in human world: A nonstop source of benefactions till the end of time
Zommiti, M., Feuilloley, M. G. J., & Connil, N. (2020) · Microorganisms · doi:10.3390/microorganisms8121907 · Cited by 225
Assessing the Risk of Probiotic Dietary Supplements in the Context of Antibiotic Resistance
Zheng, M., Zhang, R., Tian, X., Zhou, X., Pan, X., & Wong, A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00908 · Cited by 218
Metadata
- Authors
- Savaiano, D. A., Ritter, A. J., Klaenhammer, T. R., James, G. M., Longcore, A. T., Chandler, J. R., Walker, W. A., & Foyt, H. L.
- Affiliations
- Purdue University West Lafayette (US)
- North Carolina State University (US)
- University of Southern California (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Savaiano, Dennis A
- Venue
- Nutrition Journal
- Published
- 2013-12
- Volume
- 12
- Issue
- 1
- Pages
- 160-160
- ISSN
- 1475-2891 (ISSN-L)
- PMC
- PMC3878758
- OpenAlex
- W2142455021
- Cited by
- 99
- References
- 21
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 7 · 2023: 10 · 2022: 10 · 2021: 13 · 2020: 12 · 2019: 9 · 2018: 9 · 2017: 7 · 2016: 2 · 2015: 4 · 2014: 1
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrition Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Purdue e-Pubs (Purdue University System) (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Digestive system and related health
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- lactose intolerance, galactooligosaccharides, lactose digestion, abdominal pain, hydrogen breath test, gut microbiota, prebiotics, symptom improvement
- MeSH terms
- Adult, Colon, Dairy Products, Digestion, Double-Blind Method, Female, Follow-Up Studies, Gastrointestinal Agents, Humans, Intestinal Mucosa, Lactose, Lactose Intolerance, Male, Oligosaccharides, Severity of Illness Index, Trisaccharides, United States, Abdominal Pain, Incidence, Lactase, Prebiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial. https://app.cochat.ai/papers/10.1186/1475-2891-12-160
- The paper
- Savaiano, D. A., Ritter, A. J., Klaenhammer, T. R., James, G. M., Longcore, A. T., Chandler, J. R., Walker, W. A., & Foyt, H. L. (2013). Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial. Nutrition Journal. https://doi.org/10.1186/1475-2891-12-160
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.